Join our email list!

Get daily updates delivered to your inbox
Thank you for subscribing

Last Week’s Hot Topic on Multiple Sclerosis



Last week’s hot topic on Multiple Sclerosis was an article titled For MS Patients, New Guidelines for Controlling Rare Brain Infection Risk Under Tysabri Treatment, written by Patricia Inacio.

The article features a review by The European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC) on the risk for progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients treated with the medicine Tysabri (natalizumab).  The issued guidelines have the objective of minimizing patients’ risk.

Read more articles about MS here:

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *